Trials / Completed
CompletedNCT05702632
TheraTogs Versus Reciprocal Electrical Stimulation on Children With Diplegic Cerebral Palsy: a Randomized Controlled Trial
Comparison of Thera-togs Orthotics With Reciprocal Electrotherapy for Postural Stability in Spastic Diplegic Cerebral Palsy
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- Cairo University · Academic / Other
- Sex
- All
- Age
- 6 Years – 8 Years
- Healthy volunteers
- Not accepted
Summary
Children with diplegic cerebral palsy exhibit postural restrictions as a result of both primary and secondary brain damage impairments. One of the main goals of cerebral palsy rehabilitation is to improve balance and stability. As a result, the purpose of this study is to compare the effects of TheraTogs and reciprocal electrical stimulation on postural stability in children with diplegic CP.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | 1- Reciprocal electrical stimulation | A specialized programmable electrical stimulation device was used (Uniphy is the manufacturer of Phyaction787; Uniphy, Eindhoven, the Netherlands). The device has two channels that can alternatively stimulate two opposing groups of muscles (reciprocate). |
| DEVICE | TheraTogs orthotic treatment | A sleeveless top vest and two pairs of shorts with two thigh cuffs and limb cuffs each make up the TheraTogs strapping system which is applied to the children in the TheraTogs group. The TheraTogs suit is providing breathable, comfortable- Latex over the torso and thigh, as well as free toileting. For infection control and size fitting problems, participants are not allowed to share their TheraTogs with other patients. TheraTog's orthotic undergarment and strapping system were worn under their regular clothes, so it was neither distracting nor irritating. |
| PROCEDURE | traditional physical therapy program | Facilitation of balance and gait training |
Timeline
- Start date
- 2022-07-15
- Primary completion
- 2022-09-08
- Completion
- 2022-12-30
- First posted
- 2023-01-27
- Last updated
- 2023-01-27
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05702632. Inclusion in this directory is not an endorsement.